4.6 Article

Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 Mpro

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy

Runming Wang et al.

Summary: The emergence of SARS-CoV-2 variants impacts vaccine efficacy, highlighting the importance of further developing orally administered anti-SARS-CoV-2 therapies. A cocktail therapy combining colloidal bismuth subcitrate or bismuth subsalicylate with N-acetyl-l-cysteine shows potent preclinical anti-SARS-CoV-2 efficacy, offering a potential at-home treatment for combating SARS-CoV-2 and future coronavirus infections.

CHEMICAL SCIENCE (2022)

Article Chemistry, Multidisciplinary

Emerging Applications of Aryl Trifluoromethyl Diazoalkanes and Diazirines in Synthetic Transformations

Thierry Ollevier et al.

Summary: Aryl trifluoromethyl diazoalkanes and diazirines have become unique reactants in synthetic methodology. Highlighted for their versatility in applications towards a wide range of synthetic transformations, these compounds, bearing CF3 groups and accessible for synthesis, are valuable as precursors of stabilized metal carbenes.

ACS ORGANIC & INORGANIC AU (2022)

Review Pharmacology & Pharmacy

Potential SARS-CoV-2 main protease inhibitors

Riddhidev Banerjee et al.

Summary: This review focuses on recent developments in the search for small-molecule inhibitors targeting the SARS-CoV-2 M-pro, aiming at discovering and designing drugs targeting the key target in the viral replication cycle.

DRUG DISCOVERY TODAY (2021)

Review Biochemistry & Molecular Biology

Spatial and temporal roles of SARS-CoV PLpro-A snapshot

Shaomin Yan et al.

Summary: This paragraph explains the functions of the SARS virus PLpro protein and its roles in SARS-CoV infection. The cleavage and ubiquitination activities of PLpro may promote SARS-CoV replication but could also trigger immune responses.

FASEB JOURNAL (2021)

Article Biochemistry & Molecular Biology

Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses

Andrea Citarella et al.

Summary: A new method successfully synthesized a potential antiviral agent against coronaviruses, inhibiting viral replication with low cytotoxicity. The compound showed promising antiproliferative activity in cells and effectively bound to the target proteinase, with potential for activity against SARS-CoV-2.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

News Item Medicine, General & Internal

Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Chemistry, Medicinal

Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

Giorgio Amendola et al.

Summary: In 2020, the COVID-19 pandemic posed a major threat to global health and economy, prompting unprecedented efforts in drug discovery. Through virtual screening, two new lead inhibitors with inhibitory properties were identified, offering new hope for the prevention and treatment of COVID-19.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Chemistry, Multidisciplinary

Labeling Preferences of Diazirines with Protein Biomolecules

Alexander West et al.

Summary: The reactivity of alkyl and aryl diazirines with amino acids, proteins, and the cell proteome was systematically evaluated, revealing different labeling patterns. Alkyl diazirines preferentially label acidic amino acids in a pH-dependent manner, while aryl-fluorodiazirine labeling occurs mainly through a carbene intermediate. These findings help rationalize the enrichment of specific proteins by alkyl diazirine probes and the higher labeling yields of positively charged probes in cells and in vitro.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Review Biochemistry & Molecular Biology

SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors

Andrea Citarella et al.

Summary: The uncontrolled spread of COVID-19 caused by SARS-CoV-2 in 2020-2021 had devastating impacts on health, economy, and daily life globally. Despite approved vaccines, their long-term efficacy and safety are debated, prompting the search for new target-based drugs. Strategies targeting the coronavirus's main protease, M-pro, show promise for anti-coronavirus drug development.

BIOMOLECULES (2021)

Article Microbiology

The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses

Arianna Calistri et al.

Summary: The article presents a broad-spectrum CoVs antiviral activity of MEDS433, a human dihydroorotate dehydrogenase inhibitor, which has been shown to inhibit SARS-CoV-2 replication in vitro and also exhibit anti-SARS-CoV-2 activity in kidney organoids generated from human embryonic stem cells. The antiviral activity of MEDS433 was reversed by the addition of exogenous uridine or orotate, confirming hDHODH as the specific target in hCoVs-infected cells.

MICROORGANISMS (2021)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

The Taxonomy of Covalent Inhibitors

Alfred Tuley et al.

BIOCHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Diazirine based photoaffinity labeling

Luba Dubinsky et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2012)